Dapsone
NDC 33342-535, Dapsone, tablet, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-535
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218335
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPSONE100 mg/1
Pharmacologic classes
Sulfone [EPC]; Sulfones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-535-07 | 33342053507 | 30 TABLET in 1 BOTTLE (33342-535-07) |
| 33342-535-11 | 33342053511 | 100 TABLET in 1 BOTTLE (33342-535-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/839d7440-ba0e-4c56-b648-d374b155cf03
Use it
Look up 33342-535 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-535. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.